Skip to main content
Top
Published in: Archives of Osteoporosis 1/2016

01-12-2016 | Original Article

Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice

Authors: Patricia Seuffert, Carlos A. Sagebien, Matthew McDonnell, Dorene A. O′Hara

Published in: Archives of Osteoporosis | Issue 1/2016

Login to get access

Abstract

Summary

The purpose of this study was to assess whether education and referral by a nurse practitioner could improve treatment adherence in patients with low bone mineral density in the orthopedic office. Our customized project did show some improvement but resistance to care continues in this unique population of patients.

Introduction

Osteoporosis and osteopenia are significant clinical problems. Nearly 50 % of adults over the age of 50 are osteopenic (Looker et al. in Osteoporos Int 22:541–549, 2011). Many patients with osteoporosis are not taking calcium or vitamin D, or any active treatment, even after dual energy X-ray absorptiometry (DXA) and demonstration of low bone mineral density (Dell et al. in J Bone Joint Surg Am 91(Suppl 6):79–86, 2009). One hypothesis to explain low adherence with osteoporosis treatment is lack of patient education. This study was designed to compare a control group with an education-intervention group (receiving patient education from a nurse practitioner) to determine any effect of education on treatment adherence.

Methods

A total of 242 females and 105 males were studied as a control: a total of 292 females and 155 male were studied in the education group. Patients in the education group received educational materials and were counseled by a single nurse practitioner. Patients had a DXA performed and patients with osteoporosis or osteopenia were followed to assess treatment. At 12 months, patients received follow-up phone calls to determine patient use of calcium, vitamin D, and/or an active treatment. Results between the groups were compared.

Results

Significantly more patients began calcium and vitamin D after education (p = 0.04); significantly more patients were taking or were recommended for an active treatment after education (p = 0.03). Thirty percent of patients either did not follow up or refused active treatment for osteoporosis. Approximately 50 % of patients with osteoporosis were not taking an FDA-approved pharmacologic agent for osteoporosis treatment, despite education.

Conclusion

After patient education and referral to endocrinology, significantly more patients began calcium and vitamin D supplementation. However, up to 50 % of patients with osteoporosis would not complete follow-up visits and/or did not adhere to treatment recommendations for osteoporosis.
Literature
1.
go back to reference Looker AC, Dawson-Hughes B, Tosteson ANA, Johansson H, Kanis JA, Melton LJ (2011) Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. Osteoporos Int 22:541–549CrossRefPubMed Looker AC, Dawson-Hughes B, Tosteson ANA, Johansson H, Kanis JA, Melton LJ (2011) Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. Osteoporos Int 22:541–549CrossRefPubMed
2.
go back to reference Dell RM, Greene D, Anderson D, Williams K (2009) Osteoporosis disease management: what every orthopaedic surgeon should know. J Bone Joint Surg Am 91(Suppl 6):79–86CrossRefPubMed Dell RM, Greene D, Anderson D, Williams K (2009) Osteoporosis disease management: what every orthopaedic surgeon should know. J Bone Joint Surg Am 91(Suppl 6):79–86CrossRefPubMed
3.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed
4.
go back to reference Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555–1562CrossRefPubMed Bawa HS, Weick J, Dirschl DR (2015) Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample. J Bone Joint Surg Am 97:1555–1562CrossRefPubMed
5.
go back to reference Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg 85-A(9):1837–1843CrossRefPubMed Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg 85-A(9):1837–1843CrossRefPubMed
6.
go back to reference Qaseem A, Snow V, Shekelle P, Hopkins R, Forclea MA, Owens DK (2008) Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 149:404–415CrossRefPubMed Qaseem A, Snow V, Shekelle P, Hopkins R, Forclea MA, Owens DK (2008) Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 149:404–415CrossRefPubMed
8.
go back to reference American Orthopaedic Association (2005) Leadership in orthopaedics: taking a stand to own the bone. J Bone Joint Surg Am 87:1389–1391 American Orthopaedic Association (2005) Leadership in orthopaedics: taking a stand to own the bone. J Bone Joint Surg Am 87:1389–1391
9.
go back to reference Estok PJ, Sedlak CA, Doheny MO, Hall R (2007) Structural model for osteoporosis preventing behavior in postmenopausal women. Nurs Res 56:148–158CrossRefPubMed Estok PJ, Sedlak CA, Doheny MO, Hall R (2007) Structural model for osteoporosis preventing behavior in postmenopausal women. Nurs Res 56:148–158CrossRefPubMed
10.
go back to reference Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25:1439–1443CrossRefPubMedPubMedCentral Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25:1439–1443CrossRefPubMedPubMedCentral
11.
go back to reference Clyburn TA, Heydemann JA (2011) Fall prevention in the elderly: analysis and comprehensive review of methods used in the hospital and in the home. J Am Acad Orthop Surg 19:402–409CrossRefPubMed Clyburn TA, Heydemann JA (2011) Fall prevention in the elderly: analysis and comprehensive review of methods used in the hospital and in the home. J Am Acad Orthop Surg 19:402–409CrossRefPubMed
12.
go back to reference Kates SL, Blake D, Bingham KW, Kates OS, Mendelson DA, Friedman SM (2010) Comparison of an organized geriatric fracture program to United States government data. Geriatr Orthop Surg Rehabil 1:15–21CrossRefPubMedPubMedCentral Kates SL, Blake D, Bingham KW, Kates OS, Mendelson DA, Friedman SM (2010) Comparison of an organized geriatric fracture program to United States government data. Geriatr Orthop Surg Rehabil 1:15–21CrossRefPubMedPubMedCentral
13.
go back to reference Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA et al (2014) Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment of fragility fracture: secondary analyses from two controlled trials. Osteoporos Int 25:2173–2179CrossRefPubMed Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA et al (2014) Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment of fragility fracture: secondary analyses from two controlled trials. Osteoporos Int 25:2173–2179CrossRefPubMed
14.
go back to reference Schulman JE, Williams S, Khera O, Sahba T, Michelson J, Fine K (2007) Effective osteoporosis education in the outpatient orthopaedic setting. J Bone Joint Surg 89-A:301–306 Schulman JE, Williams S, Khera O, Sahba T, Michelson J, Fine K (2007) Effective osteoporosis education in the outpatient orthopaedic setting. J Bone Joint Surg 89-A:301–306
15.
go back to reference Allin S, Munce S, Carlin L, Butt D, Tu K, Hawker G et al (2014) Fracture risk assessment after BMD examination: whose job is it, anyway? Osteoporos Int 25:1445–1453CrossRefPubMedPubMedCentral Allin S, Munce S, Carlin L, Butt D, Tu K, Hawker G et al (2014) Fracture risk assessment after BMD examination: whose job is it, anyway? Osteoporos Int 25:1445–1453CrossRefPubMedPubMedCentral
16.
go back to reference Dunniway DL, Camune B, Baldwin K, Crane JK (2012) FRAX counseling for bone health behavior change in women 50 years of age and older. J Am Acad Nurse Pract 24:382–389CrossRefPubMed Dunniway DL, Camune B, Baldwin K, Crane JK (2012) FRAX counseling for bone health behavior change in women 50 years of age and older. J Am Acad Nurse Pract 24:382–389CrossRefPubMed
17.
go back to reference Kitchin B (2013) Nutrition counseling for patients with osteoporosis: a personal approach. J Clin Densitom 16:426–431CrossRefPubMed Kitchin B (2013) Nutrition counseling for patients with osteoporosis: a personal approach. J Clin Densitom 16:426–431CrossRefPubMed
19.
go back to reference Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350CrossRefPubMed Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350CrossRefPubMed
20.
go back to reference Schneider JP (2009) Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Geriatrics 64:18–23PubMed Schneider JP (2009) Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Geriatrics 64:18–23PubMed
21.
go back to reference McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098CrossRefPubMed McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098CrossRefPubMed
22.
go back to reference Rabenda V, Vanoverloop J, Fabri V, Mertens R, Smkay F, Vannecke C et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg 90:2142–2148CrossRefPubMed Rabenda V, Vanoverloop J, Fabri V, Mertens R, Smkay F, Vannecke C et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg 90:2142–2148CrossRefPubMed
23.
go back to reference Rozental TD, Makhni EC, Day CS, Bouxsein ML (2008) Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 90:953–961CrossRefPubMed Rozental TD, Makhni EC, Day CS, Bouxsein ML (2008) Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 90:953–961CrossRefPubMed
24.
go back to reference Adachi JD, Josse RG, Russell RGG (2011) If you don’t take it—it can’t work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther Clin Risk Manag 7:181–198CrossRefPubMedPubMedCentral Adachi JD, Josse RG, Russell RGG (2011) If you don’t take it—it can’t work: the consequences of not being treated or nonadherence to osteoporosis therapy. Ther Clin Risk Manag 7:181–198CrossRefPubMedPubMedCentral
25.
go back to reference Curtis JR, Cai Q, Wade SW, Stolshek BS, Adams JL, Balasubramanian A et al (2013) Osteoporosis medication adherence: physician perceptions vs patients’ utilization. Bone 55:1–6CrossRefPubMedPubMedCentral Curtis JR, Cai Q, Wade SW, Stolshek BS, Adams JL, Balasubramanian A et al (2013) Osteoporosis medication adherence: physician perceptions vs patients’ utilization. Bone 55:1–6CrossRefPubMedPubMedCentral
26.
go back to reference Bianchi MI, Duca P, Val S, Guglielmi G, Viti R, Battista C et al (2015) Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 26:1629–1638CrossRefPubMed Bianchi MI, Duca P, Val S, Guglielmi G, Viti R, Battista C et al (2015) Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 26:1629–1638CrossRefPubMed
27.
go back to reference Jeray KJ (2015) Osteoporosis and fragility fractures: what progress have we made? J Bone Joint Surg Am 97:1553–1554CrossRefPubMed Jeray KJ (2015) Osteoporosis and fragility fractures: what progress have we made? J Bone Joint Surg Am 97:1553–1554CrossRefPubMed
Metadata
Title
Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice
Authors
Patricia Seuffert
Carlos A. Sagebien
Matthew McDonnell
Dorene A. O′Hara
Publication date
01-12-2016
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2016
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-016-0262-7

Other articles of this Issue 1/2016

Archives of Osteoporosis 1/2016 Go to the issue